{"schema_version":"secwatch.filing_event.v1","accession":"0001645113-26-000026","form_type":"8-K","ticker":"NVCR","cik":"0001645113","company_name":"NovoCure Ltd","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.650120+00:00","generated_at":"2026-05-15T06:47:34.716633+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"NovoCure names Dr. Uri Weinberg CMO, adds CHF 5k/month stipend","bullets":["Dr. Uri Weinberg, previously Chief Innovation Officer, also appointed Chief Medical Officer effective April 7, 2026.","Monthly salary increased by CHF 5,000 (gross) for the duration of the CMO assignment.","Stipend not included in annual incentive payment (AIP); all other terms unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001645113-26-000026","json":"https://secwatch.observer/filing/0001645113-26-000026.json","markdown":"https://secwatch.observer/filing/0001645113-26-000026.md","text":"https://secwatch.observer/filing/0001645113-26-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645113/000164511326000026/0001645113-26-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645113/000164511326000026/nvcr-20260408.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:47:34.716633+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}